Navigation Links
The National Association for Home Care & Hospice (NAHC) Joins Sens. Susan Collins and Bob Casey and Reps. Jim McGovern and Walter Jones in Urging Access to Home Health Care
Date:10/18/2007

supporter of home health care services during my time in Congress, and I am proud to introduce this legislation," said Rep. Jim McGovern. "Making further, deep cuts in home health care services is not just wrong, it's bad fiscal policy. We know that home health care is a cost-effective, compassionate way to deliver high-quality services. The CMS proposal makes no sense, and I look forward to working with my colleagues to move our legislation through the Congress."

"Senators Collins, Casey, Bond, Reed, Cantwell and Roberts and Representatives McGovern and Jones are to be commended for their act of conscience and courage in overturning this shortsighted policy and seeking to preserve for all Americans the fundamental right articulated by the U.S. Supreme Court to be cared for in the least restrictive environment -- at home," said Val J. Halamandaris, President of the National Association for Home Care & Hospice. "We are deeply grateful that they have made this critical issue a top priority of their legislative efforts."

Jeffrey Kincheloe, Director of Government Affairs for NAHC, said that "while the need for home care is increasing, the Centers for Medicare & Medicaid Services have sought to decrease rather than increase Medicare home health funding. CMS has scheduled a $6 billion cut on Medicare home health beneficiaries who are, by definition, ill and homebound and cannot fight for themselves. Such cuts are unconscionable and out of touch with reality."

Unless Congress intervenes, fewer people will have access to care, those who do qualify will receive less care, more than 50% of all Medicare providers will be paid less than it costs them to provide services, many home health providers will go out of business, and overall Medicare costs will increase because patients who had been receiving care at home will be forced to receive their care at five to ten times the cost in overcrowded hospital emergency rooms or nursing homes. Others will simply
'/>"/>

SOURCE National Association for Home Care & Hospice
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International community warns India on HIV situation
2. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
3. National Lung Study in the process
4. Indian Nationals with Foreign Medical Degrees can now practice in India
5. Key step forward on International Health Rules
6. ICMR along with other International Research organisation with drug development for Neglected Diseases
7. International Osteoporosis Research Centre To Be Started In India.
8. Hepatitis B Vaccine To Be Included In National Immunization Programme
9. Indian hospitals require International Accreditation
10. International Conference On Malaria - Laveran To Genomics
11. UK Govt Says On Course For National Chlamydia Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...cal trials presented by Calpis Co., Ltd. at the Am...Annual Scientific Meeting and Exposition (ASH 2008...y supplement AmealPeptide reduces blood pressure i...D (Achieve Hypertension Efficacy with AmealPeptide...tive, Two-phase Randomized, Open-Label, Blinded En...
(Date:5/16/2008)... -- Superior launch strategies,allow best-in-class...,crowded markets. To secure "share of voice" for a...ptake strategies to support business needs and,ens...l companies achieve,attention in the market during...., "Best Practices for Winning Product Launch Suc...
(Date:5/16/2008)...d Information Technology That, Optimizes Cardiolo...ases Efficiency, SE...ced clinical and,information technology (IT) for t...www.siemens.com/healthcare ) will demonstrate the ...iology and cardiology workflow and image,processin...
(Date:5/16/2008)...PRNewswire-FirstCall/ -- BMP,Sunstone Corporation ...and,distribution pharmaceutical companies, today a...owing conferences:, (1) The Roth Annual China D...David Gao, Chief Executive Officer of the Company,... 2008, at 4:40 pm local time at the Regent Ho...
Breaking Medicine News(10 mins):Health News:Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials 2Health News:Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes 2Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 2Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 3Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 4Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 5Health News:BMP Sunstone Announces Participation in May Investor Conferences 2
...ers from Tufts University in Boston, eating three ...d substantially reduce the risk of developing type... ate an average of 3.5 servings of whole grains pe...s than a half a serving of whole grains// per day....
...n in a new study, that soy can lower cholesterol a...h the two new studies give more reason to dish up ...in and omega 3 fatty acids, which are found in abu...have been enhanced for their health benefits. But ...
... that children with sleep-disordered breathing suf... addition, the study shows a tremendous improvemen...on. Between 2 percent and 6 percent of preschool a...tructive sleep apnea, or upper airway obstruction....
... study, infants as young as even 3 days old can te...Teresa Farroni, study's lead author, doubts that h...very early in life as a survival necessity. Farron...ognitive Development in the School of Psychology a...
Other Medicine News:Health News:Soy, Omega 3s convalesce artery health 2Health News:Soy, Omega 3s convalesce artery health 3Health News:Tonsillectomy improves quality of life 2Health News:Newborns Know how to make eye contact 2
(Date:5/16/2008)...- BioVex Inc, a biotechnology,company...d infectious,disease, announced today that the abs...e II clinical trial of OncoVEX GM-CSF in advanced ...an Society of Clinical Oncology,(ASCO) website loc...stract,which describes the data as of the submissi...
(Date:5/16/2008)...s First-Ever PEGylation of a Small Molecule with ..., SAN CARLOS, Calif., May 16 /PRNewswire-FirstCal...ed initial results today from a Phase 1,study of N...nificant,anti-tumor activity in patients with refr...hat Nektar,s small molecule PEGylation technology,...
(Date:5/16/2008)...- Veridex, LLC announced today that,i...of America Holdings,(LabCorp), has commercially la...ncer. The new assay uses the biological specificit...ng the methylation of the gene,GST-Pi. Methylation...,cancer. Veridex is developing the methylation mar...
(Date:5/16/2008)...atistically Significant Reductions in Selected ...act to be published in 2008 Proceedings of the Ame...l Oncology, SAN DIEGO, May 16 /PRNewswire-FirstCa...) announced today that, in a registrational bioequ...atistically significant reduction,in general disor...
Breaking Medicine Technology:BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2905 1MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2905 2MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2905 3MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2905 4MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2905 5MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2905 6Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 1Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 2Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 3Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 4Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 2Christopher and Dana Reeve Foundation Awards Nearly 242 Million in Individual Research Grants 2903 1Christopher and Dana Reeve Foundation Awards Nearly 242 Million in Individual Research Grants 2903 2Christopher and Dana Reeve Foundation Awards Nearly 242 Million in Individual Research Grants 2903 3
...e/ -- Data presented,today at a major medical meet...ets administered once-daily for five days is as,ef...500 mg) for 10,days for the treatment of complicat...nephritis (AP). , Ortho-McNeil, Inc., the company ...ata during a scientific session at the annual,meet...
...% 3.5 Years Post Surgery, VIENNA, Va., May 21, 200...nounced today that its cancer drug Multikine(R) wa...l survival in a,Phase II study of head and neck ca...2007 at the First International Congress of,the In...dam, the,Netherlands, by Dr. Eyal Talor, Senior VP...
Other Medicine Technology:Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3
This dissector offers dual-action jaws, which are long, tapered, and angled 30 to simplify even difficult laparoscopic dissection.
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs.
Insulated, angled, spoon-shaped design cups the gallbladder, permits clear visualization, and allows easy dissection and control of bleeders.
The control unit manage patient temperatures during long complex surgical procedures to help achieve optimal clinical outcomes.
Medicine Products: